Vahid Makhtoomi, Pouran Raeisi, Aziz Rezapour, Hamid Pourasghari, Soudabeh Vatankhah
{"title":"Strategies for financial protection for patients with cancer or special diseases in the health system: A scoping review.","authors":"Vahid Makhtoomi, Pouran Raeisi, Aziz Rezapour, Hamid Pourasghari, Soudabeh Vatankhah","doi":"10.1186/s12961-025-01372-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Financial protection refers to the health system's ability to protect the population from the financial risk of ill health. Patients with cancer or special diseases are particularly vulnerable to catastrophic health spending and impoverishment, highlighting the urgent need for targeted financial protection strategies. Diseases such as haemophilia, thalassemia, dialysis, renal replacement therapy and multiple sclerosis (MS) are among the list of special diseases in Iran. This scoping review aims to identify existing strategies for financial protection for patients with cancer or special diseases in health systems.</p><p><strong>Methods: </strong>This scoping review utilized the Arksey and O'Malley framework and used the population-context-concept model to review publications related to financial protection for patients with cancer or special diseases from 2000 to 2024. The data were collected from three databases (PubMed, Institute for Scientific Information (ISI) Web of Science and Scopus) and two search engines (Google and Google Scholar). The keywords included \"financial protection,\" \"financial risk protection,\" \"health insurance coverage,\" \"poor people\" and \"health services.\"</p><p><strong>Results: </strong>A total of 4625 articles were found, 17 of which were ultimately included in the final analysis. We identified seven main types of strategies for financial protection in health systems, including purchasing, prepaid mechanisms, financial support, benefits packages, infrastructure and facilities, intersectoral collaboration and economic support.</p><p><strong>Conclusion: </strong>Prepaid mechanisms are the most widely used main component of financial protection for patients with cancer and special diseases. Policy-makers and healthcare stakeholders must prioritize adaptable and context-specific solutions that account for local economic, social and healthcare realities.</p>","PeriodicalId":12870,"journal":{"name":"Health Research Policy and Systems","volume":"23 1","pages":"121"},"PeriodicalIF":3.2000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12505804/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Research Policy and Systems","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12961-025-01372-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Financial protection refers to the health system's ability to protect the population from the financial risk of ill health. Patients with cancer or special diseases are particularly vulnerable to catastrophic health spending and impoverishment, highlighting the urgent need for targeted financial protection strategies. Diseases such as haemophilia, thalassemia, dialysis, renal replacement therapy and multiple sclerosis (MS) are among the list of special diseases in Iran. This scoping review aims to identify existing strategies for financial protection for patients with cancer or special diseases in health systems.
Methods: This scoping review utilized the Arksey and O'Malley framework and used the population-context-concept model to review publications related to financial protection for patients with cancer or special diseases from 2000 to 2024. The data were collected from three databases (PubMed, Institute for Scientific Information (ISI) Web of Science and Scopus) and two search engines (Google and Google Scholar). The keywords included "financial protection," "financial risk protection," "health insurance coverage," "poor people" and "health services."
Results: A total of 4625 articles were found, 17 of which were ultimately included in the final analysis. We identified seven main types of strategies for financial protection in health systems, including purchasing, prepaid mechanisms, financial support, benefits packages, infrastructure and facilities, intersectoral collaboration and economic support.
Conclusion: Prepaid mechanisms are the most widely used main component of financial protection for patients with cancer and special diseases. Policy-makers and healthcare stakeholders must prioritize adaptable and context-specific solutions that account for local economic, social and healthcare realities.
背景:财务保护是指卫生系统保护人群免受健康不良财务风险的能力。患有癌症或特殊疾病的患者特别容易受到灾难性保健支出和贫困的影响,这突出表明迫切需要制定有针对性的财务保护战略。血友病、地中海贫血、透析、肾脏替代疗法和多发性硬化症等疾病都属于伊朗的特殊疾病。本次范围审查的目的是确定卫生系统中癌症或特殊疾病患者财务保护的现有战略。方法:本综述采用Arksey和O'Malley框架,并使用人口-情境-概念模型对2000年至2024年癌症或特殊疾病患者财务保护相关的出版物进行综述。数据来自三个数据库(PubMed, Institute for Scientific Information (ISI) Web of Science和Scopus)和两个搜索引擎(谷歌和谷歌Scholar)。关键词包括“金融保护”、“金融风险保护”、“健康保险”、“穷人”和“卫生服务”。结果:共检索到4625篇文献,其中17篇最终纳入最终分析。我们确定了卫生系统财务保护的七种主要战略类型,包括采购、预付机制、财务支持、一揽子福利、基础设施和设施、部门间合作和经济支持。结论:预付费机制是癌症及特殊疾病患者经济保障中应用最广泛的主要组成部分。政策制定者和医疗保健利益攸关方必须优先考虑适应性强和具体情况的解决方案,以考虑当地的经济、社会和医疗保健现实。
期刊介绍:
Health Research Policy and Systems is an Open Access, peer-reviewed, online journal that aims to provide a platform for the global research community to share their views, findings, insights and successes. Health Research Policy and Systems considers manuscripts that investigate the role of evidence-based health policy and health research systems in ensuring the efficient utilization and application of knowledge to improve health and health equity, especially in developing countries. Research is the foundation for improvements in public health. The problem is that people involved in different areas of research, together with managers and administrators in charge of research entities, do not communicate sufficiently with each other.